Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.09
-0.85 (-7.12%)
At close: Aug 28, 2026, 4:00 PM EDT
11.14
+0.05 (0.45%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 115 employees as of June 30, 2026. The number of employees increased by 10 or 9.52% compared to the same quarter last year.
Employees
115
Change
10
Growth
9.52%
Revenue / Employee
n/a
Profits / Employee
-$789,748
Market Cap
542.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 115 | 10 | 9.52% |
| Mar 31, 2026 | 106 | 10 | 10.42% |
| Dec 31, 2025 | 104 | 15 | 16.85% |
| Sep 30, 2025 | 106 | 24 | 29.27% |
| Jun 30, 2025 | 105 | 23 | 28.05% |
| Mar 31, 2025 | 96 | 15 | 18.52% |
| Dec 31, 2024 | 89 | 8 | 9.88% |
| Sep 30, 2024 | 82 | - | - |
| Jun 30, 2024 | 82 | - | - |
| Mar 31, 2024 | 81 | - | - |
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| Capricor Therapeutics | 231 |
| ARS Pharmaceuticals | 200 |
| Cabaletta Bio | 158 |
| Kyverna Therapeutics | 149 |
| Scribe Therapeutics | 89 |
| Prelude Therapeutics | 79 |
| Zura Bio | 40 |
ARTV News
- 23 days ago - Artiva Biotherapeutics files $400M mixed securities shelf - TheFly
- 23 days ago - Artiva Biotherapeutics reports Q2 EPS (63c), consensus (64c) - TheFly
- 23 days ago - Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 23 days ago - Artiva Biotherapeutics Registration statement: Registration filing - Filings
- 23 days ago - Artiva Biotherapeutics Quarterly report: Q2 2026 - Filings
- 23 days ago - Artiva Biotherapeutics Earnings release: Q2 2026 - Filings
- 26 days ago - Artiva Biotherapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire